Provided by Tiger Trade Technology Pte. Ltd.

CVS Health

71.29
-0.1900-0.27%
Post-market: 71.20-0.0900-0.13%17:45 EDT
Volume:8.15M
Turnover:580.63M
Market Cap:90.50B
PE:51.29
High:72.46
Open:72.29
Low:70.61
Close:71.48
52wk High:85.15
52wk Low:58.35
Shares:1.27B
Float Shares:1.27B
Volume Ratio:0.84
T/O Rate:0.64%
Dividend:2.66
Dividend Rate:3.73%
EPS(TTM):1.39
EPS(LYR):1.39
ROE:2.29%
ROA:2.47%
PB:1.20
PE(LYR):51.29

Loading ...

CVS Health Q4 Total REV $105.69 Bln VS Ibes Estimate $103.59 Bln

THOMSON REUTERS
·
Feb 10

CVS Health Q4 Medical Benefit Ratio at 94.8% VS Ibes Estimate 95.5%

THOMSON REUTERS
·
Feb 10

CVS Profit, Revenue Climb as Turmoil Continues in Health-Insurance Sector

Dow Jones
·
Feb 10

CVS Health Resets Costs And Footprint As Valuation Signals Potential Upside

Simply Wall St.
·
Feb 10

Republican-led US House panel issues subpoenas to eight health insurers, Axios reports

Reuters
·
Feb 10

U.S. Earnings Preview: Before Market Open Feb. 10

Dow Jones
·
Feb 10

Coca-Cola, CVS Health And 3 Stocks To Watch Heading Into Tuesday

Benzinga_recent_news
·
Feb 10

Review & Preview: A Broadening Bull -- Barrons.com

Dow Jones
·
Feb 10

Notable companies reporting before tomorrow’s open

TIPRANKS
·
Feb 10

Jobs, Consumer Prices, Coinbase, Robinhood, AppLovin, Coca-Cola, Ford, and More: What to Watch This Week

Dow Jones
·
Feb 09

A Look At CVS Health (CVS) Valuation As Regulatory And Medicaid Pressures Challenge Growth

Simply Wall St.
·
Feb 08

Preview -- Barron's

Dow Jones
·
Feb 07

CVS Health akzeptiert TrumpRx-Rabattkarten in allen Apotheken

Reuters
·
Feb 07

CVS Health Corp: CVS Pharmacy NOW Accepting Trumprx Discount Cards

THOMSON REUTERS
·
Feb 07

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

Benzinga_recent_news
·
Feb 07

CORRECTED-CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)

Reuters
·
Feb 06

Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That. -- Barrons.com

Dow Jones
·
Feb 06

BRIEF-CVS Health Helps Customers Accelerate Biosimilar Adoption Through Formulary Changes For Affordable Osteoporosis Care

Reuters
·
Feb 05

CVS Health Corp: Effective April 1, 2026, CVS Caremark Will Also Begin Offering Generic Teriparatide, Bonsity, and Tymlos

THOMSON REUTERS
·
Feb 05

CVS Health Helps Customers Accelerate Biosimilar Adoption Through Formulary Changes - Supporting Affordable Options for Osteoporosis Care

THOMSON REUTERS
·
Feb 05